Abbott India Limited vs Accenture plc
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Accenture plc (Management consulting and information technology services) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Accenture plc leads on Revenue (approx.).
Accenture plc leads on Revenue (approx.).
The right choice depends on the buyer’s priorities, since Abbott India and Accenture operate in very different sectors. Choose Abbott India if you want exposure to Indian branded pharmaceuticals, supported by recognized chronic and specialty brands, doctor and pharmacy distribution, and Abbott Laboratories parentage. Choose Accenture if you prefer a global consulting and technology services business with diversified services, large enterprise relationships, and capabilities in cloud, data, AI, and digital transformation. Be mindful that Abbott is more exposed to India’s pharma market and price controls, while Accenture is more exposed to discretionary enterprise technology spending and workforce utilization pressures.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Accenture plc | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately US$65 billion, rounded and unverified here | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Accenture plc
Management consulting and information technology services · Ireland
Accenture is a global professional services company providing strategy, consulting, technology, operations, and digital transformation services. It serves large enterprises, governments, and institutions across many industries, with significant capabilities in cloud, data, artificial intelligence, cybersecurity, and business process services.
Verified financials
Strengths
- Global scale and diversified service portfolio
- Strong relationships with large enterprise clients
- Deep capabilities in cloud, data, AI, and digital transformation
- Broad industry expertise and delivery footprint
Weaknesses
- Exposure to discretionary enterprise technology spending cycles
- Complex global workforce and delivery model
- Dependence on maintaining high utilization and talent retention
- Premium positioning can face pricing pressure from lower-cost competitors
Opportunities
- Enterprise adoption of generative AI and automation
- Continued cloud migration and modernization demand
- Growth in cybersecurity, data governance, and managed services
- Expansion through targeted acquisitions and industry-specific platforms
Threats
- Macroeconomic slowdowns reducing consulting budgets
- Intense competition from global consulting and IT services firms
- Rapid technology shifts requiring continuous reskilling
- Regulatory, geopolitical, and data privacy risks across markets
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Accenture plc: which company leads overall?
Accenture plc leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Digital Payments Market — Intelligence Report
Embedded Finance & Banking-as-a-Service (BaaS) Market — Intelligence Report
Global Digital Payments & Real-Time Rails Market — Intelligence Report
UAE Logistics & Warehousing Management System Market — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Accenture plc's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is an Indian pharmaceuticals company and listed subsidiary of Abbott Laboratories, marketing branded prescription and over-the-counter healthcare products.
- Abbott India Limited operates across therapeutic areas including gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
- Accenture plc is an Ireland-based global professional services company providing strategy, consulting, technology, operations, and digital transformation services.
- Notable: Accenture reported revenue of 69,672,977,000 USD and net income of 7,678,433,000 USD in 2025, with total assets of 55,932,363,000 USD in 2024.